Reported 2026-05-29Lot IPCI20-052026-499.89% purity · Ipamorelin – 11.27 mg, CJC-1295 – 11.19 mg
Open COA
Lyophilized Peptides
Ipamorelin/CJC-1295 (w/o DAC)
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogIPCJ-PW-5MG-5MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$65.00 — or Original price was: $65.00.$55.25Current price is: $55.25. / month Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
8923 in stock
Subscribe monthly and save 15%$55.25 per delivery. The same price applies to the first order and recurring renewals.
- Guest checkout
- All major cards
- COA per lot
- 2-day shipping
- Cancel anytime
Ipamorelin/CJC-1295 (w/o DAC)$65.00COA available
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
9 approved certificates are attached to this product record.
Reported 2026-05-01Lot IPC110-042026-0499.95% purity · Ipamorelin – 6.34 mg, CJC-1295 – 4.82 mg
Open COA
Reported 2026-05-01Lot IPC110-042026-0499.95% purity · Ipamorelin – 6.34 mg, CJC-1295 – 4.82 mg
Open COA
View all historical COAs (6)
Reported 2026-05-01Lot CIIP 105-042026-199.82% purity · Ipamorelin – 6.45 mg, CIC-1295 – 10.27 mg
Open COA
Reported 2026-04-29Lot IPCJ10-042026-199.64% purity · Ipamorelin – 5.03 mg, CJC-1295 – 5.35 mg
Open COA
Reported 2026-01-31Lot IPCJD127202G-J99.772% purity · Ipamorelin – 4.84 mg, CJC-1295 – 5.82 mg
Open COA
Reported 2025-12-11Lot IDCJ12092025-J99.854% purity · Ipamorelin – 6.38 mg CJC-1295 – 5.62 mg
Open COA
Reported 2025-08-20Lot CJCIPA508142025-0399.07% purity · Ipamorelin: 4.29 mg CJC-1295: 6.08 mg
Open COA
Reported 2025-07-30Lot CJC/PA5072525025-0399.22% purity · Ipamorelin: 4.39 mg CJC-1295: 5.42 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- IPCJ-PW-5MG-5MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference IPCJ-PW-5MG-5MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model
